All Sauce from Weekly Sauce:

Dementia patients who suffer from seizures tend to decline faster and die younger, according to a new study that urges caregivers to watch for these sudden brain changes. “Our hope is that controlling seizures by prescribing antiseizure medications to these patients will slow down the progression of cognitive impairment,” said Dr. Ifrah Zawar, lead study…  read on >  read on >

Costs for epilepsy medications in the United States are skyrocketing, outpacing inflation and straining federal insurers Medicare and Medicaid, according to new research. Spending on antiseizure medications more than doubled in eight years for the government insurers, largely because of third-generation and brand-name drugs, the study found. “While it’s very important that Medicare and Medicaid…  read on >  read on >

Moms-to-be can safely take Paxlovid to help keep their COVID infection from turning serious, a new study shows. Nearly everyone in a group of 47 pregnant women prescribed Paxlovid did well on the drug, which did not appear to interfere with their pregnancy in any significant way, researchers report in the Nov. 29 issue of…  read on >  read on >

COVID-19 may harm the liver, a small study suggests. The virus appears to increase liver stiffness, a sign of potential long-term injury, but it’s too early to tell if that portends serious liver disease, the researchers said. “COVID infections have been observed to cause inflammation and damage to a number of different organ systems like…  read on >  read on >

The U.S. Food and Drug Administration on Wednesday approved the first fecal microbiota treatment, aimed at helping adults battling tough-to-treat Clostridium difficile (C. diff) infections. “Today’s approval of Rebyota is an advance in caring for patients who have recurrent C. difficile infection [CDI],” said Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation…  read on >  read on >